Treace Medical Concepts, Inc. (TMCI) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts TMCI Hot Sheet
Join SI Premium – FREE
Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.28), $0.01 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $47.39 million versus the consensus estimate of $47.08 million.
For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Dawson Geophysical (DWSN) Reports Q2 Loss of $0.11
- Actelis Networks (ASNS) Tops Q2 EPS by 63c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
